News Website

NMPA clears drugs from Innovent/Hutchmed, Hengrui, Henlius, Luye - BioWorld Online

NMPA clears drugs from Innovent/Hutchmed, Hengrui, Henlius, Luye BioWorld Online

Published: Dec. 5, 2024, 9:35 p.m.

Read Full Article

Connecticut Blocks Anthem's Proposed Anesthesia Coverage Limits After Anesthesiologists Bash The 'Cynical Money Grab' - Medical Daily

Connecticut Blocks Anthem's Proposed Anesthesia Coverage Limits After Anesthesiologists Bash The 'Cynical Money Grab' Medical Daily

Published: Dec. 5, 2024, 9:28 p.m.

Read Full Article

Study links depression to increased menstrual pain - Contemporary Pediatrics

Study links depression to increased menstrual pain Contemporary Pediatrics

Published: Dec. 5, 2024, 9:08 p.m.

Read Full Article

Immunotherapy Redefines Standard of Care for Frontline Advanced Endometrial Cancer - OncLive

Immunotherapy Redefines Standard of Care for Frontline Advanced Endometrial Cancer OncLive

Published: Dec. 5, 2024, 7:04 p.m.

Read Full Article

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - The Malaysian Reserve

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer The Malaysian Reserve

Published: Dec. 5, 2024, 3:36 p.m.

Read Full Article

Protein Loss Predicts EC Prognosis - Physician's Weekly

Protein Loss Predicts EC Prognosis Physician's Weekly

Published: Dec. 5, 2024, 3:24 p.m.

Read Full Article

Gaps Identified in EC Clinical Trial Enrollment - Physician's Weekly

Gaps Identified in EC Clinical Trial Enrollment Physician's Weekly

Published: Dec. 5, 2024, 3:09 p.m.

Read Full Article

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - Canada NewsWire

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer Canada NewsWire

Published: Dec. 5, 2024, 2:43 p.m.

Read Full Article

Supreme Court seems ready to uphold ban on gender-affirming care for minors - Texas Standard

Supreme Court seems ready to uphold ban on gender-affirming care for minors Texas Standard

Published: Dec. 5, 2024, 2:42 p.m.

Read Full Article

Adenomyosis has relatively high long-term recurrence rate after conservative surgery, finds study - Medical Dialogues

Adenomyosis has relatively high long-term recurrence rate after conservative surgery, finds study Medical Dialogues

Published: Dec. 5, 2024, 2:30 p.m.

Read Full Article

Latest Articles

NMPA clears drugs from Innovent/Hutchmed, Hengrui, Henlius, Luye - BioWorld Online

Connecticut Blocks Anthem's Proposed Anesthesia Coverage Limits After Anesthesiologists Bash The 'Cynical Money Grab' - Medical Daily

Study links depression to increased menstrual pain - Contemporary Pediatrics

Immunotherapy Redefines Standard of Care for Frontline Advanced Endometrial Cancer - OncLive

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - The Malaysian Reserve

Protein Loss Predicts EC Prognosis - Physician's Weekly

Gaps Identified in EC Clinical Trial Enrollment - Physician's Weekly

Nova Scotia becomes first province to publicly reimburse JEMPERLI for the treatment of patients with advanced or recurrent dMMR/MSI-H endometrial cancer - Canada NewsWire

Supreme Court seems ready to uphold ban on gender-affirming care for minors - Texas Standard

Adenomyosis has relatively high long-term recurrence rate after conservative surgery, finds study - Medical Dialogues

Subscribe to Our Newsletter